Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati

Translated title of the contribution: Avascular jaw osteonecrosis associated with bisphophonate therapy

Chiara Broglia, Giuseppe Merlati, Francesco Valentino, Chiara Benatti, Paolo Gobbi, Edoardo Ascari

Research output: Contribution to journalArticle

Abstract

The case of an IgAk myeloma showed the following common features with more than a hundred of patients described by the literature: osteonecrosis of the jaws, prolonged administration of bisphosphonates due to neoplastic skeletal lesions, antitumoral therapies and recent dental surgery. The antiangiogenetic effects of bisphosphonates can have an important pathogenetic role and a general dental treatment should be completed before the start of bisphosphonate administration.

Translated title of the contributionAvascular jaw osteonecrosis associated with bisphophonate therapy
Original languageItalian
Pages (from-to)140-144
Number of pages5
JournalRecenti Progressi in Medicina
Volume97
Issue number3
Publication statusPublished - Mar 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Avascular jaw osteonecrosis associated with bisphophonate therapy'. Together they form a unique fingerprint.

  • Cite this

    Broglia, C., Merlati, G., Valentino, F., Benatti, C., Gobbi, P., & Ascari, E. (2006). Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati. Recenti Progressi in Medicina, 97(3), 140-144.